Head and Neck Hyperpigmentation Probably Associated With Polymyxin B Therapy

Abstract

Get full access to this article

View all access options for this article.

References

Mostardeiro

Pereira

Marra

Pestana

Camargo

. Nephrotoxicity and efficacy assessment of polymyxin use in 92 transplant patients. Antimicrob Agents Chemother. 2013;57:1442-1446.

Knueppel

Rahimian

. Diffuse cutaneous hyperpigmentation due to tigecycline or polymyxin B. Clin Infect Dis. 2007;45:136-138.

Sutiman

Tan

Rowe

. Polymyxin B toxicities: critical appraisal of nephrotoxicity and novel dermatological toxicity.Paper presented at: 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); September 10-13, 2013; Denver, CO. Abstract K-182.

Shih

Gaik

. Polymyxin B induced generalized skin hyperpigmentation in infants. J Pediatr Sci. 2014;6:e215.

Bliss

Warnock

. Psychiatric medications: adverse cutaneous drug reactions. Clin Dermatol. 2013;31:101-109.

Naranjo

Busto

Sellers

. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.